Skip to content

Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices

Measurements of Cerebrospinal Fluid Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06513572
Enrollment
10
Registered
2024-07-22
Start date
2024-07-25
Completion date
2024-07-27
Last updated
2025-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydrocephalus

Brief summary

This study collects data using non-invasive devices for assessing CSF shunt flow using thermal anisotropy measurements in a prospective study setting. The study will collect data to compare measurements from flowing shunts, non-flowing shunts, and off-shunt locations.

Interventions

DEVICEFlowSense

This study collects data using non-invasive devices for assessing CSF shunt flow using thermal anisotropy measurements in a prospective study setting. The study will collect data to compare measurements from flowing shunts, non-flowing shunts, and off-shunt locations.

Sponsors

Rhaeos, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. At least one existing ventricular CSF shunt, functional or non-functional (including an adjustable valve set to virtual off, ligated shunt, uncorrected distal catheter disconnection or fracture, distal catheter fragment left in place during shunt surgery, or indication that the shunt is otherwise non-functional), with a region of overlying intact skin appropriate in size for application of the study device 2. If more than one distal shunt catheter is present, at least one distal shunt catheter is at least 2 cm away from any other distal shunt catheter in the device measurement region 3. Signed informed consent by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes) 4. Signed medical records release by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes) 5. Verbal assent by minors 7 years of age and older who are able to understand the study and communicate their decision

Exclusion criteria

1. Presence of an interfering open wound or edema in the FlowSense device measurement area 2. Patient-reported history of serious adverse skin reactions to silicone-based adhesives 3. Use of the study device would interfere with standard patient care, or emergency surgery that cannot be delayed, or participation in the study will interfere with, or be detrimental to, administration of optimal healthcare to the subject 4. Participation in any other investigational procedural, pharmaceutical, and/or device study that may influence the collection of valid data under this study

Design outcomes

Primary

MeasureTime frameDescription
Correlation of measurement dataApproximately 1 hourCorrelation between measurements from flowing shunts, non-flowing shunts, and off-shunt locations.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026